Sort
16,300 grants matching “fatty liver disease”
Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity
$504,912Jesus Antonio Araujo · University Of California Los Angeles · R01 · FY2025 · ES
Glucocorticoid-regulated transcription networks in macrophage biology
$504,907Inez Rogatsky · Hospital For Special Surgery · R01 · FY2021 · DK
Role of Adipokine FABP4 in Glucoregulation and Counter Regulatory Responses
$504,849Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2020 · DK
Role of Adipokine FABP4 in Glucoregulation and Counter Regulatory Responses
$504,846Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2021 · DK
Role of Adipokine FABP4 in Glucoregulation and Counter Regulatory Responses
$504,846Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2023 · DK
Investigating intracellular cholesterol biosynthesis as a regulator of polycystic kidney disease progression
$504,621Ronak Lakhia · Ut Southwestern Medical Center · R01 · FY2025 · DK
Brain endoplasmic reticulum stress in non-alcoholic fatty liver disease
$504,620Colin Neal Young · George Washington University · R01 · FY2018 · DK
Mitochondrial dynamics in VMH neurons control glucose metabolism
$504,424Sabrina Diano · Columbia University Health Sciences · R01 · FY2022 · DK
Tissue Responses to Metabolic Stress
$504,247Jean E Schaffer · Washington University · R01 · FY2017 · DK
Metabolic inflexibility is related to elevated muscle anaerobic glycolysis
$504,124Joseph A Houmard · East Carolina University · R01 · FY2023 · DK
HIV HCV Coinfection Antiviral Therapy and Fibrosis
$504,056David L Thomas · Johns Hopkins University · R01 · FY2009 · DA
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and
$504,042Adrian Friedrich Gombart · Oregon State University · R01 · FY2015 · AT
Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates
$503,945Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2014 · AI
Mechanisms and therapeutic potential of blocking the mitochondrial Mg2+ channel Mrs2 in obesity and NAFLD
$503,933Madesh Muniswamy · University Of Texas Hlth Science Center · R01 · FY2024 · DK
Microbiome, metabolites, and alcohol in HIV to reduce CVD Cohort (META HIV CVD Cohort)
$503,806Kaku So-Armah · Vanderbilt University Medical Center · P01 · FY2024 · AA
Emory Epithelial Pathobiology Research Development Center
$503,750Charles A Parkos · Emory University · R24 · FY2012 · DK
Viral mechanisms of adipocyte dysfuntion: Role of Vpr.
$503,522Ashok Balasubramanyam · Baylor College Of Medicine · R01 · FY2009 · DK
Regulation of Rhythmic m6A RNA Modification by ERâassociated Degradation
$503,374Kezhong Zhang · Wayne State University · R01 · FY2024 · DK
Effect of Alcohol on Obesity Related Liver Disease
$503,279Arun J Sanyal · Virginia Commonwealth University · R01 · FY2011 · AA
Novel pathophysiological insights into mitochondrial fatty acid oxidation disorders
$503,244Sander Michel Houten · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DK
Advanced C-arm imaging platform for histotripsy treatment of liver tumors
$503,242Paul F Laeseke · University Of Wisconsin-Madison · R01 · FY2025 · EB
Understanding the metabolic pathology of pediatric obesity and NAFLD
$503,196Kevin R. Short · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · DK
Growth Hormone Regulation of Sex Differences in Liver Metabolism
$503,133David J Waxman · Boston University (Charles River Campus) · R01 · FY2020 · DK
Effects of ethanol and CYP2E1 on liver function
$503,005Arthur I Cederbaum · Icahn School Of Medicine At Mount Sinai · R56 · FY2007 · AA
Comprehensive quantitative ultrafast 3D liver MRI
$502,849Vikas Gulani · Case Western Reserve University · R01 · FY2014 · DK